Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Wanglong Zheng

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

Oncogenesis

Mechanistic study identifying a signaling pathway and demonstrating synergy in preclinical models, but lacking clinical evidence or phase-appropriate human trials to support clinical practice.

Hypothesis-GeneratingProstate Cancer Treatment and Research Peng Liang Yulin Peng

Reported

Ferroptosis inducer panel screened13

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support